Filing Details
- Accession Number:
- 0001209191-17-006522
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-31 20:34:38
- Reporting Period:
- 2017-01-27
- Filing Date:
- 2017-01-31
- Accepted Time:
- 2017-01-31 20:34:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1513818 | Versartis Inc. | VSAR | Pharmaceutical Preparations (2834) | 264106690 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1587788 | Jay Shepard | C/O Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park CA 94025 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-01-27 | 64,700 | $0.00 | 220,058 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2017-01-27 | 10,000 | $0.00 | 230,058 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2017-01-30 | 6,674 | $13.85 | 223,384 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-01-30 | 10,596 | $2.53 | 233,980 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-01-30 | 10,596 | $13.31 | 223,384 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2017-01-27 | 144,900 | $0.00 | 144,900 | $14.30 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-01-30 | 10,596 | $0.00 | 10,596 | $2.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 144,900 | 2027-01-26 | No | 4 | A | Direct | |
| 108,398 | 2023-12-27 | No | 4 | M | Direct |
Footnotes
- Represents the grant of Restricted Stock Units that vest as follows: 25% of the shares subject to the award vest on each of the first, second, third and fourth anniversaries of the date of grant, respectively, subject to the officer's continuous service on each applicable vesting date.
- Represents the grant of Restricted Stock Units that vest as follows: 33.33%, 33.33% and 33.34% of the shares subject to the award vest on each of the first, second and third anniversaries of the date of grant, respectively, subject to the officer's continuous service on each applicable vesting date.
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant.
- Shares sold pursuant to 10b5-1 plan.
- The shares were sold at prices ranging from $12.90 to $13.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- 1/48th of the shares subject to the option become exercisable monthly measured from the date of grant.
- Fully vested.
Billionaire Hedge Funds
